| CLOI | CLOX | CLOI / CLOX | |
| Gain YTD | 0.518 | 0.527 | 98% |
| Net Assets | 1.34B | 291M | 461% |
| Total Expense Ratio | 0.36 | 0.20 | 180% |
| Turnover | 68.00 | 65.00 | 105% |
| Yield | 5.58 | 5.16 | 108% |
| Fund Existence | 4 years | 3 years | - |
| CLOI | CLOX | |
|---|---|---|
| RSI ODDS (%) | N/A | 1 day ago 2% |
| Stochastic ODDS (%) | 1 day ago 4% | 1 day ago 3% |
| Momentum ODDS (%) | N/A | 1 day ago 44% |
| MACD ODDS (%) | 1 day ago 18% | N/A |
| TrendWeek ODDS (%) | 1 day ago 24% | 1 day ago 18% |
| TrendMonth ODDS (%) | 1 day ago 21% | 1 day ago 19% |
| Advances ODDS (%) | 3 days ago 26% | 1 day ago 18% |
| Declines ODDS (%) | N/A | N/A |
| BollingerBands ODDS (%) | 1 day ago 4% | 1 day ago 5% |
| Aroon ODDS (%) | 1 day ago 19% | 1 day ago 15% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| FEXRX | 13.35 | 0.12 | +0.91% |
| First Eagle U.S. SMID Cap Opportunity R6 | |||
| THCVX | 29.56 | 0.05 | +0.17% |
| Nuveen Large Cap Value Idx I | |||
| BMSVX | 15.43 | N/A | N/A |
| MFS Blended Research Mid Cap Eq R4 | |||
| SBFIX | 22.86 | -0.01 | -0.04% |
| Federated Hermes Global Allocation IS | |||
| TOTTX | 10.36 | -0.09 | -0.86% |
| Transamerica Mid Cap Value Opps I3 | |||